TABLE 3.
Susceptibilities of surveillance study strains compared to those of clinical isolates obtained in 1994 and 1995a
| Organism (no. of strains) | % Isolates susceptible to the following agents:
|
||||
|---|---|---|---|---|---|
| Amphotericin B | Flucytosine | Fluconazole | Ketoconazole | Miconazole | |
| C. albicans (70/50/65) | 100/98/98 | 90/88/88 | 90/86/86 | 96/80/96 | 94/78/84 |
| C. glabrata (15/20/31) | 100/85/98 | 100/95/100 | 100/85/87 | 100/100/100 | 100/95/96 |
| C. tropicalis (7/14/13) | 100/93/100 | 100/86/80 | 86/57/85 | 100/71/85 | 86/21/75 |
| C. krusei (8/0/7) | 88/—b/67 | 0/—/0 | 0/—/0 | 100/—/100 | 13/—/13 |
| C. parapsilosis (1/0/15) | 100/—/100 | 100/—/100 | 100/—/100 | 100/—/100 | 100/—/75 |
a
Data are for surveillance isolates/clinical isolates obtained in 1994/clinical isolates obtained in 1995.
b
—, There were no isolates of C. krusei or C. parapsilosis recovered in 1994.